Iron absorption in erythropoietin-treated haemodialysis patients: effects of iron availability, inflammation and aluminium.

@article{Kooistra1998IronAI,
  title={Iron absorption in erythropoietin-treated haemodialysis patients: effects of iron availability, inflammation and aluminium.},
  author={Menno P Kooistra and E C Niemantsverdriet and Armelle Van Es and N M Mol-Beermann and A. Struyvenberg and James J. Marx},
  journal={Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association},
  year={1998},
  volume={13 1},
  pages={82-8}
}
BACKGROUND The response to recombinant human erythropoietin (rHuEpo) is determined primarily by the availability of iron. In contrast to i.v., iron, oral iron supplementation is often insufficient for an optimal response. METHOD We studied iron absorption and the effects of iron status, aluminium status and inflammation in 19 chronic haemodialysis patients on maintenance rHuEpo therapy. Iron mucosal uptake after 24 h, iron retention after 2 weeks and mucosal transfer of iron were determined… CONTINUE READING

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
31 Extracted Citations
0 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 31 extracted citations

Similar Papers

Loading similar papers…